Remedy Entertainment, the Finnish video game developer known for titles such as Control and Alan Wake, has a new chief executive. Jean-Charles Gaudechon has stated that the company will now prioritise its own intellectual property and focus on maximising the potential of its core franchises.
Gaudechon, who recently assumed the role of CEO, outlined the studio’s strategic shift during a recent interview. He indicated that the company will learn from its previous operational mistakes to guide its future development efforts.
Strategic focus on internal brands
The primary directive for Remedy moving forward is a concentration on its owned IP. This approach marks a significant focus on franchises that the studio controls directly, rather than work-for-hire projects or external collaborations.
Gaudechon emphasised the importance of these core franchises. The studio plans to maximise their potential through careful development and long-term planning, rather than short-term releases.
This strategy aligns with industry trends where developers seek greater control over their creative assets and revenue streams. By owning its IP, Remedy can dictate release schedules, licensing terms, and platform distribution without external constraints.
Learning from operational errors
The new CEO acknowledged that the company has made mistakes in its past operations. These errors served as learning opportunities for the leadership team. Gaudechon did not specify particular projects or decisions, but the statement reflects a broader assessment of the studio’s recent performance.
Remedy has faced challenges with project management and release timing in recent years. The company previously struggled with the development cycle of Control and the Alan Wake franchise, leading to delays and resource allocation issues. The new leadership aims to streamline these processes.
Gaudechon’s comments suggest a more disciplined approach to game development. This includes better resource management, clearer milestone setting, and improved communication between teams.
Financial implications
The shift to prioritising owned IP could have significant financial benefits for Remedy. Owned franchises generate higher margins over time compared to licensed properties, as the developer retains full royalty rights and licensing fees.
However, this strategy also carries risk. In-house IP requires substantial investment in marketing and brand development. If a title fails to connect with audiences, the financial impact falls entirely on the developer, unlike licensed projects where the IP holder shares some marketing burden.
Industry context
The move by Remedy is part of a broader industry trend. Several major developers, including Epic Games and Bungie, have moved toward building and controlling their own IP portfolios. This strategy provides long-term stability and creative independence.
For Remedy, its most valuable assets include the Control universe and the Alan Wake franchise. Both have established fan bases and critical acclaim. The studio has already begun expanding these universes through sequels and cross-media projects.
Analysts note that Remedy’s decision comes at a time when the gaming industry faces consolidation and increased competition for talent. Owning strong IP helps attract both developers and publishers interested in partnership opportunities.
Looking ahead
Remedy plans to continue development on its announced projects under the new strategic direction. The studio is working on multiple titles based on its owned franchises, as well as a cooperative multiplayer game set in the Control universe.
Gaudechon stated that the company will apply lessons from past mistakes to ensure smoother development cycles. The goal is to deliver high quality products on schedule while maintaining creative control.
The gaming community will monitor Remedy’s next announcements closely. The company is expected to provide updates on its upcoming projects within the next fiscal year, including release windows and platform details.
Source: GamesIndustry.biz
